CareMetx, LLC的动态

Patient Services Leaders: Imagine the next big step in patient care coming from how we accelerate therapy access. Integrated, provider-centric solutions are changing the game, and I’m eager to discuss innovative strategies at the Patient Services Congress in Philadelphia next week. Let’s connect and explore new ideas! #AccessSolutions #PharmaInnovation #PatientSupport2024

No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows: Today’s guest post comes from Shabbir Ahmed, Chief Commercial Officer at CareMetx. Shabbir explains the barriers that providers face when dealing with branded portals for multiple products. He then maintains that patients can access new therapies more quickly when the manufacturer relies on a brand-agnostic hub connected to a large network of providers and integrated with the systems those providers use daily. To learn more, download CareMetx’s new 2024 Patient Services Report:?Revealing Manufacturer Priorities: Patients Naturally Take Center Stage. Read on for Shabbir’s insights. Read more ? ? 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute, an HMP Global Company. All rights reserved. This Feed is for personal non-commercial use only. #pbm #lifesciences #financial

No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows: Today’s guest post comes from Shabbir Ahmed, Chief Commercial Officer at CareMetx. Shabbir explains the barriers that providers face when dealing with branded portals for multiple products. He then maintains that patients can access new therapies more quickly when the manufacturer relies on a brand-agnostic hub connected to a large network of providers and integrated with the systems those providers use daily. To learn more, download CareMetx’s new 2024 Patient Services Report:?Revealing Manufacturer Priorities: Patients Naturally Take Center Stage. Read on for Shabbir’s insights. Read more ? ? 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute, an HMP Global Company. All rights reserved. This Feed is for personal non-commercial use only. #pbm #lifesciences #financial

Are you preparing to submit a MedTech product to the Drug Tariff? Then here’s a worthwhile read! Speaking with the Journal of mHealth, Richard Tuson, CEO and Founder of Health Analytical Solutions, discusses what companies need to consider when submitting products to the Drug Tariff and gives examples of submissions he’s worked on where cost effectiveness has been successfully demonstrated: https://lnkd.in/e8bUwgTB #MedTech #Drugtariff #NHS #thegekodevice

Are you preparing to submit a MedTech product to the Drug Tariff? Then here’s a worthwhile read! Speaking with the Journal of mHealth, Richard Tuson, CEO and Founder of Health Analytical Solutions, discusses what companies need to consider when submitting products to the Drug Tariff and gives examples of submissions he’s worked on where cost effectiveness has been successfully demonstrated: https://lnkd.in/e8bUwgTB #MedTech #Drugtariff #NHS #thegekodevice

Are you preparing to submit a MedTech product to the Drug Tariff? Then here’s a worthwhile read! Speaking with the Journal of mHealth, Richard Tuson, CEO and Founder of Health Analytical Solutions, discusses what companies need to consider when submitting products to the Drug Tariff and gives examples of submissions he’s worked on where cost effectiveness has been successfully demonstrated: https://lnkd.in/e8bUwgTB #MedTech #Drugtariff #NHS #thegekodevice

We are witnessing the dawn of a new era in healthcare with direct-to-consumer care becoming a norm. The rising popularity of telemedicine and virtual care has thrust DTC into the spotlight as the new normal in healthcare delivery. Consumers and manufacturers are welcoming this change with open arms. What is driving and keeping this change afloat? Affordability, Accessibility, convenience, and personalization. The DTC model eliminates the middleman that bloats the price of medicines, streamlining the pharmaceutical supply chain. It brings transparency in pricing and lowers cost making it more affordable. By leveraging telemedicine, the DTC model not only offers a convenient solution, but also makes healthcare more accessible for consumers in remote areas. Reduced costs are a win-win situation for both pharma companies and consumers alike. As illustrated by Eli Lilly, having direct control over distribution and pricing sets DTC companies apart, making it a preferred choice. By offering transparency and personalised care such models stand a step ahead of the traditional healthcare structures. A recent survey unveiled a 34% patient preference for telehealth over traditional care. Consumers are voting with their feet, and pharmaceutical companies are already aligning themselves accordingly. Men's telehealth leader Hims raked in a 57% revenue uptick in 2023 with ambitious plans to expand its prescription drug vertical. We are witnessing DTC penetration at an unprecedented pace and can only be expected to scale over time. Read the full story here: https://zurl.co/BErH #medicine #pharma #DTC #industry #business #telemedicine #EliLilly #Hims #change #Xcellen

Pharmacogenomics continues to emerge as an increasingly valuable decision support tool for prescribers, according to a presentation at the Outcomes 2024 SYNC National Conference in Orlando in late February.? ? Pacience Edwards, PharmD, explained to conference attendees that through pharmacogenomics, prescribers can determine with greater certainty, for example, if their patient is among the 1 in 10 who are poor metabolizers of codeine, which can lead to negative side effects,?Drug Topics?reported.? ? Similarly, we, at FDB, have shown that incorporating knowledge seamlessly into workflows can help maximize the benefit and efficiency of pharmacogenomics technology, resulting in safer and more effective care.

Get ready to take your pharmacy to the next level! ?? ?? From e-prescriptions to telehealth services, find out how you can revolutionize your patient experience today! ???? ?? Discover the latest technologies that will streamline your operations, elevate patient care, and bring smiles to your customers' faces! ???? ???? Stay with us! Follow RxOnWeb for more practical healthcare insights.? . . . #pharmacy #pharma #pharmacies #pharmacyspotlight #pharmaindustry #pharmacy?? #pharmacylife?? #pharmacist #rxonweb #technologies #upgrade #power #medical #medicine #patient #doctors #consultations #transformation #pharmacien #newreel #trendingreels #tech #digitalmarketing #socialmediamarketing #joinus

Merging market research with regulatory considerations can significantly alter the MedTech playing field. In our latest blog post, our seasoned Clinical and Regulatory leader, Prem Narayan Pandey, highlights the synergy of these critical facets. Discover how this strategic integration enhances decision-making, guiding you to select the ideal market for your MedTech product. Read the full blog: https://lnkd.in/dvtF_h4S #marketresearch #medicaldevice #pmcf #medtech #eumdr #euregulation #medtechinsights #medicaldeviceindustry #regulatoryaffairs